These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Properties of tetracycline hydrochloride tablets and their bioavailability]. Zak AF; Batuashvili TA; Loseva GI; Shatrova VM; Ermolova OB Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222 [TBL] [Abstract][Full Text] [Related]
4. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
5. Film-coated zinc sulphate tablets and the effect of humidity on tablet properties. Gürsoy A; Akbuğa J Pharmazie; 1986 Aug; 41(8):575-8. PubMed ID: 3786379 [TBL] [Abstract][Full Text] [Related]
6. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals]. Zak AF; Ermolova OB Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466 [TBL] [Abstract][Full Text] [Related]
7. Stability of cyanocobalamin in sugar-coated tablets. Ohmori S; Kataoka M; Koyama H Int J Pharm; 2007 Jun; 337(1-2):161-8. PubMed ID: 17300886 [TBL] [Abstract][Full Text] [Related]
8. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 3. Effect of lubricants. Asker A; el-Nakeeb M; Motawi M; el-Gindy N Pharmazie; 1973 Jul; 28(7):476-8. PubMed ID: 4767501 [No Abstract] [Full Text] [Related]
9. Development and evaluation of the tablets coated with the novel formulation termed thin-layer sugarless coated tablets. Ohmori S; Ohno Y; Makino T; Kashihara T Int J Pharm; 2004 Jul; 278(2):459-69. PubMed ID: 15196649 [TBL] [Abstract][Full Text] [Related]
10. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations]. Thoma K; Heckenmüller H Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846 [TBL] [Abstract][Full Text] [Related]
11. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55. Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872 [TBL] [Abstract][Full Text] [Related]
12. Influence of compression forces on tablets disintegration by AC Biosusceptometry. Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605 [TBL] [Abstract][Full Text] [Related]
13. Enteric coating derived from marine sponge collagen. Nicklas M; Schatton W; Heinemann S; Hanke T; Kreuter J Drug Dev Ind Pharm; 2009 Nov; 35(11):1384-8. PubMed ID: 19832639 [TBL] [Abstract][Full Text] [Related]
14. A preliminary study of the physical stability of tablets prepared from powders stored under tropical conditions. York P Pharmazie; 1976 Jun; 31(6):383-6. PubMed ID: 959298 [TBL] [Abstract][Full Text] [Related]
15. Silk fibroin as a novel coating material for controlled release of theophylline. Bayraktar O; Malay O; Ozgarip Y; Batigün A Eur J Pharm Biopharm; 2005 Aug; 60(3):373-81. PubMed ID: 15996578 [TBL] [Abstract][Full Text] [Related]
16. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants. Asker A; el-Nakeeb M; Motawi M; el-Gindy N Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500 [No Abstract] [Full Text] [Related]
17. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 1. Effect of binders. Asker A; el-Nakeeb M; Motawi M; el-Gindy N Pharmazie; 1972 Sep; 27(9):600-3. PubMed ID: 5086358 [No Abstract] [Full Text] [Related]
18. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic]. Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252 [TBL] [Abstract][Full Text] [Related]
19. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765 [TBL] [Abstract][Full Text] [Related]
20. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms]. Thoma K; Oschmann R Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]